Systems Analysis of Arrestin Pathway Functions - Progress in Molecular Biology and Translational Science - page 447

44. Luttrell LM, Roudabush FL, Choy EW, et al. Activation and targeting of extracellular
signal-regulated kinases by b -arrestin scaffolds. Proc Natl Acad Sci USA . 2001;98:
2449- 2454.
45. Tohgo A, Pierce KL, Choy EW, Lefkowitz RJ, Luttrell LM. b -Arrestin scaffolding of
the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated tran-
scription following angiotensin AT1a receptor stimulation. J Biol Chem . 2002;277:
9429- 9436.
46. Povsic TJ, Kohout TA, Lefkowitz RJ. b -Arrestin1 mediates insulin-like growth factor
1 (IGF-1) activation of phosphatidylinositol 3-kinase (PI3K) and anti-apoptosis. J Biol
Chem . 2003;278:51334 - 51339.
47. Noma T, Lemaire A, Naga Prasad SV, et al. b -Arrestin-mediated b 1-adrenergic recep-
tor transactivation of the EGFR confers cardioprotection. J Clin Invest . 2007;117:
2445- 2458.
48. Kim J, Ahn S, Rajagopal K, Lefkowitz RJ. Independent b -arrestin2 and Gq/protein
kinase C z pathways for ERK stimulated by angiotensin type 1A receptors in vascular
smooth muscle cells converge on transactivation of the epidermal growth factor recep-
tor. J Biol Chem . 2009;284:11953 - 11962.
49. Imamura T, Huang J, Dalle S, et al. b -Arrestin-mediated recruitment of the Src family
kinase Yes mediates endothelin-1-stimulated glucose transport. J Biol Chem . 2001;
276:43663 - 43667.
50. Barlic J, Andrews JD, Kelvin AA, et al. Regulation of tyrosine kinase activation and
granule release through b -arrestin by CXCRI. Nat Immunol . 2000;1:227- 233.
51. Hunton DL, Barnes WG, Kim J, et al. b -Arrestin 2-dependent angiotensin II type 1A
receptor-mediated pathway of chemotaxis. Mol Pharmacol . 2005;67:1229- 1236.
52. Ge L, Ly Y, Hollenberg M, DeFea K. A b -arrestin dependent scaffold is associated with
prolonged MAPK activation in pseudopodia during protease-activated receptor-2-
induced chemotaxis. J Biol Chem . 2003;278:34418 - 34426.
53. DeFea KA, Vaughn ZD, O'Bryan EM, Nishijima D, D´ry O, Bunnett NW. The
proliferative and antiapoptotic effects of substance P are facilitated by formation of a
b -arrestin-dependent scaffolding complex. Proc Natl Acad Sci USA . 2000;97:

11086 - 11091.
54. Revankar CM, Vines CM, Cimino DF, Prossnitz ER. Arrestins block G protein-
coupled receptor-mediated apoptosis. J Biol Chem . 2004;279:24578 - 24584.
55. Ahn S, Kim J, Hara MR, Ren XR, Lefkowitz RJ. b -Arrestin-2 mediates anti-apoptotic
signaling through regulation of BAD phosphorylation. J Biol Chem . 2009;284:

8855- 8865.
56. Gao H, Sun Y, Wu Y, et al. Identification of b -arrestin2 as a G protein-coupled
receptor-stimulated regulator of NF- k B pathways. Mol Cell . 2004;14:303- 317.
57. Kang J, Shi Y, Xiang B, et al. A nuclear function of b -arrestin1 in GPCR signaling:
regulation of histone acetylation and gene transcription. Cell . 2005;123:833 - 847.
58. Bryja V, Gradl D, Schambony A, Arenas E, Schulte G. b -Arrestin is a necessary com-
ponent of Wnt/ b -catenin signaling in vitro and in vivo. Proc Natl Acad Sci USA .
2007;104:6690 - 6695.
59. DeWire SM, Kim J, Whalen EJ, Ahn S, Chen M, Lefkowitz RJ. b -Arrestin-mediated
signaling regulates protein synthesis. J Biol Chem . 2008;283:10611 - 10620.
60. Martin B, Brenneman R, Becker KG, Gucek M, Cole RN, Maudsley S. iTRAQ anal-
ysis of complex proteome alterations in 3xTgAD Alzheimer's mice: understanding the
interface between physiology and disease. PLoS One . 2008;3:e2750.
61. Chadwick W, Brenneman R, Martin B, Maudsley S. Complex and multidimensional
lipid raft alterations in a murine model of Alzheimer's disease. Int J Alzheimers Dis .
2010;2010:604792.